3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Depression
5
Breast Neoplasms
5
Neoplasms
4
Anxiety Disorders
3
Ovarian Neoplasms
2
Glioma
2
Glioblastoma
2
Esophageal Neoplasms
2
Uterine Neoplasms
1
Sleep Wake Disorders
1
Sleep Initiation and Maintenance Disorders
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Post-traumatic Stress Symptoms
1
Patient Compliance
1
Pancreatic Neoplasms
1
Pain
1
Multiple Myeloma
1
Motor Activity
1
Lymphoma
1
Lung Neoplasms
1
Leukemia, Myeloid, Acute
1
Leukemia
1
Frailty
1
Fatigue
1
Endometrial Neoplasms
1
Caregiving for Cancer
1
Brain Neoplasms
1
Interventions
Paclitaxel
42
Carboplatin
35
pembrolizumab
25
Surveys and Questionnaires
23
Letrozole
15
Radiotherapy
14
Megestrol Acetate
14
Blood Specimen Collection
14
Bevacizumab
13
olaparib
12
Metformin
12
dostarlimab
10
Indocyanine Green
10
durvalumab
9
Observation
9
Medroxyprogesterone Acetate
9
Cisplatin
9
lenvatinib
8
atezolizumab
8
Early Intervention, Educational
8
Counseling
8
niraparib
7
Sentinel Lymph Node Biopsy
7
Radiation
7
Methods
7
Magnetic Resonance Spectroscopy
7
Lymph Node Excision
7
Hysterectomy
7
Everolimus
7
abemaciclib
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Endometrial Neoplasms
×
Psychosocial Intervention
×
Clear all
NCT04789694
2026-03-19
PHOCUS
Charles University, Czech Republic
Phase 3
Recruiting
64 enrolled